Pharvaris N.V. SEC filings and other documents

Explore the latest company documents and SEC filings from Pharvaris N.V., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Morgan Stanley 23rd Annual Global Healthcare Conference

Sep 10, 2025

Transcript

H.C. Wainwright 27th Annual Global Investment Conference

Sep 9, 2025

Transcript

Cantor Global Healthcare Conference 2025

Sep 3, 2025

Transcript

Q2 2025

Aug 11, 2025

Earnings release8-K

Oppenheimer 35th Annual Healthcare Life Sciences Conference 2025

Feb 12, 2025

Transcript

2024

Q4 2024

Apr 6, 2025

Earnings release8-K

Annual report20-F

Q3 2024

Nov 12, 2024

Earnings release8-K

Q2 2024

Aug 14, 2024

Earnings release8-K

Q1 2024

May 8, 2024

Earnings release8-K

2023

Q4 2023

Apr 10, 2024

Annual report20-F

Earnings release8-K

Q3 2023

Nov 2, 2023

Earnings release8-K

Q2 2023

Aug 7, 2023

Earnings release8-K

Q1 2023

May 8, 2023

Earnings release8-K

2022

Q4 2022

Apr 5, 2023

Annual report20-F

Earnings release8-K

Study Result

Dec 8, 2022

Slides

Press release

Q3 2022

Dec 8, 2022

Earnings release8-K

Q2 2022

Sep 12, 2022

Earnings release8-K

Q1 2022

May 11, 2022

Earnings release8-K

2021

Q4 2021

Mar 29, 2022

Annual report20-F

Earnings release8-K

Q3 2021

Nov 10, 2021

Earnings release8-K

Q2 2021

Jul 30, 2021

Earnings release8-K

Q1 2021

May 26, 2021

Earnings release8-K

2020

Q4 2020

Apr 29, 2021

Annual report10-K